
Kura Oncology, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Indicators
2025-10-07 20:43:28Kura Oncology, Inc. has recently revised its evaluation amid market dynamics, with its stock priced at $9.80. The company has faced significant volatility over the past year, with a notable performance in the short term, while longer-term returns indicate challenges compared to broader market indices.
Read MoreIs Kura Oncology, Inc. technically bullish or bearish?
2025-10-07 12:15:48As of 3 October 2025, the technical trend for Kura Oncology, Inc. has changed from bullish to mildly bullish. The weekly MACD and Bollinger Bands indicate a bullish stance, while the monthly MACD and KST are bearish. The daily moving averages are bullish, and Dow Theory shows a mildly bullish trend on both weekly and monthly time frames. The RSI shows no signal in both weekly and monthly periods. In terms of performance, Kura has outperformed the S&P 500 over the past week and month, with returns of 9.25% and 19.22% respectively, but has significantly underperformed over the longer term, with a 1-year return of -45.68% compared to the S&P 500's 17.82%. Overall, the current technical stance is mildly bullish, driven primarily by the weekly indicators....
Read MoreIs Kura Oncology, Inc. technically bullish or bearish?
2025-10-06 12:05:58As of 3 October 2025, the technical trend for Kura Oncology, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is bearish, indicating mixed signals across time frames. The daily moving averages are bullish, supporting the mildly bullish stance. However, the monthly Bollinger Bands and KST are mildly bearish, which adds some caution. Dow Theory shows a mildly bullish outlook on both weekly and monthly charts. In terms of performance, Kura has outperformed the S&P 500 over the past week and month, with returns of 5.75% and 13.52%, respectively, compared to 1.09% and 4.15% for the index. However, the longer-term returns are significantly lagging, with a 1-year return of -47.36% versus 17.82% for the S&P 500, and a 5-year return of -68.10% compared to 100.56% for the index. Overall, the current technical stance is mildly bullish, but caution is warranted given...
Read MoreIs Kura Oncology, Inc. technically bullish or bearish?
2025-10-05 11:50:49As of 3 October 2025, the technical trend for Kura Oncology, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is bearish, indicating mixed signals across time frames. The daily moving averages are bullish, supporting the mildly bullish stance. The weekly Bollinger Bands are bullish, but the monthly Bollinger Bands are mildly bearish, adding to the mixed outlook. Dow Theory shows a mildly bullish trend in both weekly and monthly assessments. In terms of performance, Kura has outperformed the S&P 500 in the past week and month, with returns of 5.75% and 13.52% respectively, but has significantly underperformed over longer periods, particularly the 1-year and 3-year returns, which are -47.36% and -26.78% compared to the S&P 500's 17.82% and 82.57%. Overall, the current technical stance is mildly bullish, driven by the positive indicators in the weekly timefr...
Read More
Kura Oncology, Inc. Experiences Evaluation Revision Amid Mixed Market Performance Indicators
2025-09-30 16:16:09Kura Oncology, Inc. has recently experienced a price increase, closing at $9.05 after previously being at $8.36. The stock's performance shows mixed technical indicators, with varying trends in momentum. Over the past week, it outperformed the S&P 500, but has struggled over the past year.
Read MoreIs Kura Oncology, Inc. technically bullish or bearish?
2025-09-29 11:17:22As of 26 September 2025, the technical trend for Kura Oncology, Inc. has changed from mildly bullish to bullish. The current stance is bullish with a strong emphasis on daily moving averages and weekly MACD, both indicating positive momentum. The weekly Bollinger Bands and KST also support this bullish outlook, while the monthly indicators show some bearish signals, particularly in MACD and KST. The Dow Theory indicates a mildly bullish trend in both weekly and monthly assessments. In terms of performance, Kura Oncology has outperformed the S&P 500 over the past week and month, with returns of 9.70% and 19.39% respectively, while it has significantly underperformed over the longer term, particularly in the 1Y, 3Y, and 5Y periods....
Read MoreIs Kura Oncology, Inc. technically bullish or bearish?
2025-09-28 11:11:21As of 26 September 2025, the technical trend for Kura Oncology, Inc. has changed from mildly bullish to bullish. The current stance is bullish, supported by a bullish MACD on the weekly timeframe, bullish moving averages on the daily timeframe, and bullish Bollinger Bands on the weekly timeframe. The RSI shows a bullish signal on the monthly timeframe, while the Dow Theory indicates a mildly bullish stance on both weekly and monthly periods. However, the monthly MACD and KST are bearish, which suggests some caution. The stock has outperformed the S&P 500 over the past week and month, returning 9.70% and 19.39% respectively, while it has significantly underperformed over the longer term, with a 1-year return of -53.49% compared to the S&P 500's 15.64%....
Read More
Kura Oncology Forms Golden Cross, Signaling Potential Bullish Breakout Ahead
2025-09-25 16:58:48Kura Oncology, Inc. has recently experienced a Golden Cross, indicating a potential shift in momentum. The stock has shown daily and weekly performance gains, contrasting with broader market trends. Despite ongoing profitability challenges, technical indicators suggest a mixed outlook, with some signs of bullish sentiment emerging.
Read MoreIs Kura Oncology, Inc. technically bullish or bearish?
2025-09-20 19:28:11As of 9 September 2025, the technical trend for Kura Oncology, Inc. has changed from mildly bearish to sideways. The current technical stance is neutral, with mixed signals across various indicators. The weekly MACD is mildly bullish, while the monthly MACD remains bearish. The weekly RSI shows no signal, but the monthly RSI is bullish. Bollinger Bands indicate a bullish stance weekly but mildly bearish monthly. Daily moving averages are mildly bearish, and the KST shows a bullish weekly but bearish monthly trend. Dow Theory indicates no trend weekly and mildly bullish monthly. The OBV is mildly bullish for both weekly and monthly periods. In terms of performance, Kura has underperformed against the S&P 500 across multiple periods, with a 1-year return of -58.34% compared to the S&P's 17.14%, and a 5-year return of -71.91% versus the S&P's 96.61%....
Read More





